Juan J. Ruano-Sanchez
Toledo, CM 45004, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
TRPM5 rs886277 Polymorphism Predicts Hepatic Fibrosis Progression in Non-Cirrhotic HCV-Infected Patients.
Journal: Journal of clinical medicine
Published: December 20, 2020
Characteristics and survival of hepatocellular carcinoma in non-cirrhotic liver.
Journal: Revista espanola de enfermedades digestivas
Published: September 10, 2019
The Myeloid-Epithelial-Reproductive Tyrosine Kinase (MERTK) rs4374383 Polymorphism Predicts Progression of Liver Fibrosis in Hepatitis C Virus-Infected Patients: A Longitudinal Study.
Journal: Journal of clinical medicine
Published: October 19, 2018
Effectiveness and safety of elbasvir/grazoprevir therapy in patients with chronic HCV infection: Results from the Spanish HEPA-C real-world cohort.
Journal: Journal of viral hepatitis
Published: May 23, 2018
Eight weeks of Paritaprevir/r/Ombitasvir + Dasabuvir in HCV genotype 1b with mild-moderate fibrosis: Results from a real-world cohort.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: May 22, 2018
The IL7RA rs6897932 polymorphism is associated with progression of liver fibrosis in patients with chronic hepatitis C: Repeated measurements design.
Journal: PloS one
Published: February 01, 2018
PNPLA3 rs738409 polymorphism is associated with liver fibrosis progression in patients with chronic hepatitis C: A repeated measures study.
Journal: Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology
Published: December 27, 2017
CXCL9-11 polymorphisms are associated with liver fibrosis in patients with chronic hepatitis C: a cross-sectional study.
Journal: Clinical and translational medicine
Published: April 04, 2017
Last Updated: 09/26/2026